FDA opens offices in China

Pia Christensen

About Pia Christensen

Pia Christensen (@AHCJ_Pia) is the managing editor/online services for AHCJ. She manages the content and development of healthjournalism.org, coordinates AHCJ's social media efforts and edits and manages production of association guides, programs and newsletters.

Following a series of crises involving food and drug products imported from China, the U.S. Food and Drug Administration is opening offices in Beijing, Guangzhou and Shangai this week.

Two recent articles about the safety of imports from China and the FDA’s lack of oversight provide some background:

  • Time: Heparin’s deadly side effects – Reporter Bill Powell follows the manufacturing process of heparin in China, noting that “It is jarring to see where a drug like heparin begins.”
  • The New York Times Magazine: The safety gap – Gardiner Harris says he has “rarely written about a subject that both branded and generic drug makers wanted to discuss less.”

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.